SCHEMBL2171624

SCHEMBL2171624

CCOc1ccc(NC(=O)NCc2nc(C(=O)NCCc3cccc(Cl)c3)cs2)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CNR1 P21554 3/20 0.51
IGF1R P08069 1/20 0.47
KMT2A Q03164 5/20 0.47
POLB P06746 1/20 0.47
TP53 P04637 2/20 0.47
MAPT P10636 4/20 0.45
LMNA P02545 4/20 0.45
RAB9A P51151 3/20 0.45
ALDH1A1 P00352 2/20 0.45
SMN1; SMN2 Q16637 2/20 0.44
KDM4E B2RXH2 1/20 0.44
RECQL P46063 1/20 0.44
HPGD P15428 1/20 0.44
NPC1 O15118 1/20 0.44
MEN1 O00255 2/20 0.44
HIF1A Q16665 1/20 0.44
L3MBTL1 Q9Y468 1/20 0.43
NAMPT P43490 1/20 0.43
GAA P10253 1/20 0.43
ALOX12 P18054 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2172958 0.90 CNR1 (0.54) CNR1IGF1RKMT2APOLBMAPT
SCHEMBL2173689 0.87 CNR1 (0.53) CNR1IGF1RKMT2APOLBMAPT
SCHEMBL5668546 0.82 IGF1R (0.49) IGF1RKMT2APOLBTP53MAPT
SCHEMBL10126403 0.81 IGF1R (0.52) IGF1RKMT2ATP53MAPTLMNA
SCHEMBL2174484 0.80 IGF1R (0.49) IGF1RKMT2ATP53MAPTRAB9A
SCHEMBL5670028 0.80 IGF1R (0.56) IGF1RKMT2AMAPTLMNARAB9A
SCHEMBL19882503 0.80 TRPV1 (0.46) CNR1IGF1RKMT2ATP53MAPT
SCHEMBL4385586 0.80 IGF1R (0.48) IGF1RKMT2ATP53MAPTLMNA
SCHEMBL5668870 0.79 IGF1R (0.51) IGF1RKMT2ATP53MAPTRAB9A
SCHEMBL2174354 0.78 HDAC3 (0.52) IGF1RKMT2AMAPTLMNARAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730128-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE Exelixis, Inc. (US) 2006-12-13 EP claimed
WO-2005097765-A1 ANAPLASTIC LYMPHOMA KINASE MODULATORS AND METHODS OF USE EXELIXIS, INC. (US) 2005-10-20 WO claimed
US-7973061-B2 Anaplastic lymphoma kinase modulators and methods of use EXELIXIS, INC. (US) 2011-07-05 US disclosed